Hajat, Cother
Stein, Emma
Selya, Arielle
Polosa, Riccardo http://orcid.org/0000-0002-8450-5721
Alaimo, Salvatore
Anfuso, Carmelina Daniela
Barbagallo, Ignazio
Basile, Francesco
Battiato, Sebastiano
Benhamou, Brahim
Bertino, Gaetano
Bianchi, Alberto
Biondi, Antonio G
Brandi, Maria Luisa
Cacciola, Emma
Cacciola, Rossella R
Cacopardo, Bruno Santi
Calogero, Aldo E
Cambria, Maria Teresa
Campagna, Davide
Caraci, Filippo
Cariola, Agatino
Caruso, Massimo
Caponnetto, Pasquale
Ciancio, Adriana
Cibella, Fabio
Mauro, Maurizio di
Piazza, Jennifer di
Stefano, Adriana di
Drago, Filippo
Failla, Salvatore
Faraci, Rosario
Ferlito, Salvatore
Ferrante, Margherita
Ferro, Alfredo
Ferro, Giancarlo A
Frasca, Francesco
Frittitta, Lucia
Furneri, Pio M
Gagliano, Antonio
Gallo, Giovanni
Galvano, Fabio
Grasso, Giuseppe
Guarino, Francesca
Gulino, Antonino
Jannini, Emmanuele A
Vignera, Sandro La
Lazzarino, Giuseppe
Ledda, Caterina
Leonardi, Rosalia Maria
Volti, Giovanni Li
Longo, Antonio
Lupo, Gabriella
Malerba, Mario
Marletta, Luigi
Nicolosi, Guido
Nocera, Francesco
Conti, Gea Oliveri
Palazzo, Giuseppe
Parenti, Rosalba
Pedullà, Eugenio
Pulvirenti, Alfredo
Purrello, Francesco
Rapisarda, Francesco
Rapisarda, Venerando
Rizzo, Renata
Ronsisvalle, Simone
Ronsisvalle, Giuseppe
Ruggieri, Martino
Santagati, Maria C
Satriano, Cristina
Sciacca, Laura
Signorelli, Maria Salvina
Tatullo, Marco
Tibullo, Daniele
Tomaselli, Venera
Volarevic, Vladislav
Zanoli, Luca
Zappalà, Agata
,
Funding for this research was provided by:
Foundation for a Smoke-Free World (GG0014 - ECLAT)
Article History
Received: 24 January 2022
Accepted: 28 February 2022
First Online: 24 March 2022
Change Date: 15 June 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11739-022-03022-9
Declarations
:
: CH received reimbursement from ECLAT for research conducted on tobacco harm reduction (2019–2020) including this article; she has served as a paid member of the advisory panel for the Tobacco Transformation Index (contracted by Sustainability, Sept 2019–April 2020); she is a paid consultant to TEVA pharmaceuticals on work related to multiple chronic conditions (2017 to present). ES received reimbursement from ECLAT for research conducted on tobacco harm reduction (2019–2020) including this article. AS is an employee of Pinney Associates, Inc., which provides consulting services on tobacco harm reduction to JUUL Labs, Inc. However, JUUL had no role in this study. RP is full tenured professor of Internal Medicine at the University of Catania (Italy) and Medical Director of the Institute for Internal Medicine and Clinical Immunology at the same University. In relation to his recent work in the area of respiratory diseases, clinical immunology, and tobacco control, RP has received lecture fees and research funding from Pfizer, GlaxoSmithKline, CV Therapeutics, NeuroSearch A/S, Sandoz, MSD, Boehringer Ingelheim, Novartis, Duska Therapeutics, and Forest Laboratories. Lecture fees from a number of European EC industry and trade associations (including FIVAPE in France and FIESEL in Italy) were directly donated to vaper advocacy no-profit organizations. RP has also received grants from European Commission initiatives (U-BIOPRED and AIRPROM) and from the Integral Rheumatology & Immunology Specialists Network (IRIS) initiative. He has also served as a consultant for Pfizer, Global Health Alliance for treatment of tobacco dependence, CV Therapeutics, Boehringer Ingelheim, Novartis, Duska Therapeutics, ECITA (Electronic Cigarette Industry Trade Association, in the UK), Arbi Group Srl., Health Diplomats, and Sermo Inc. RP has served on the Medical and Scientific Advisory Board of Cordex Pharma, Inc., CV Therapeutics, Duska Therapeutics Inc, Pfizer, and PharmaCielo. RP is also founder of the Center for Tobacco prevention and treatment (CPCT) at the University of Catania and of the Center of Excellence for the acceleration of HArm Reduction (CoEHAR) at the same University, which has received support from Foundation for a Smoke Free World to conduct 8 independent investigator-initiated research projects on harm reduction. RP currently involved in a patent application concerning an app tracker for smoking behavior developed for ECLAT Srl. RP is also currently involved in the following pro bono activities: scientific advisor for LIAF, Lega Italiana Anti Fumo (Italian acronym for Italian Anti-Smoking League), the Consumer Advocates for Smoke-free Alternatives (CASAA) and the International Network of Nicotine Consumers Organizations (INNCO); Chair of the European Technical Committee for standardization on “Requirements and test methods for emissions of electronic cigarettes” (CEN/TC 437; WG4).
: Not applicable.
: Not applicable.